Page last updated: 2024-08-18

pyridostigmine bromide and Congenital Adrenal Hyperplasia

pyridostigmine bromide has been researched along with Congenital Adrenal Hyperplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutler, GB; Irony, I1

Other Studies

1 other study(ies) available for pyridostigmine bromide and Congenital Adrenal Hyperplasia

ArticleYear
Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Clinical endocrinology, 1999, Volume: 51, Issue:3

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Carbenoxolone; Cholinesterase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fludrocortisone; Growth Hormone-Releasing Hormone; Hormones; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Hypothalamo-Hypophyseal System; Male; Mineralocorticoids; Pilot Projects; Pituitary-Adrenal System; Pyridostigmine Bromide; Renin

1999